Morgan Stanley Knock-Out PPGN/ DE000MG0H0G6 /
| 2024-11-11 4:23:39 PM | Chg.-0.080 | Bid10:00:38 PM | Ask10:00:38 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.900EUR | -8.16% | - Bid Size: - |
- Ask Size: - |
POLYPEPTIDE N | 22.3255 CHF | 2078-12-31 | Call |
GlobeNewswire
08-31
Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates
GlobeNewswire
08-13
Meso Numismatics, a Renowned Leader in Regenerative Medical, Announces Global Stem Cells Groups (GSC...
GlobeNewswire
08-05
Terns Pharmaceuticals Reports Second Quarter 2024 Financial Results and Corporate Updates
GlobeNewswire
07-08
Truveta’s real-world data study comparing tirzepatide (Mounjaro) and semaglutide (Ozempic) for weigh...
GlobeNewswire
06-05
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at th...
GlobeNewswire
05-13
Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates
GlobeNewswire
05-08
ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting...
GlobeNewswire
03-29
Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates
GlobeNewswire
03-14
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Upda...
GlobeNewswire
03-05
Gain Therapeutics Presents Data at the AD/PD™ 2024 Conference Demonstrating the Mechanism of Action ...
GlobeNewswire
01-10
NORDICUS PARTNERS CORPORATION ENTERS INTO A CONSULTANCY AGREEMENT WITH OROCIDIN A/S IN DENMARK
GlobeNewswire
01-04
Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. M...
GlobeNewswire
2023-12-14
Vandria Announces $20.6M (CHF18M) Series A Financing Led by ND Capital to Drive CNS Clinical Program...
GlobeNewswire
2023-12-01
Gain Therapeutics Announces Preclinical Data Showing Restoration of Enzymatic Function with Novel Al...
GlobeNewswire
2023-11-27
Largest real-world study finds tirzepatide (Mounjaro) up to three times more effective than semaglut...
GlobeNewswire
2023-11-02
Terns Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of TERN-601 Oral G...
GlobeNewswire
2023-10-02
Assembly Biosciences Nominates Development Candidate ABI-6250, an Orally Bioavailable HDV Entry Inhi...
GlobeNewswire
2023-09-19
Assembly Biosciences to Highlight Pipeline Progress in HBV and HDV at the 2023 International HBV Mee...
GlobeNewswire
2023-08-31
Junshi Biosciences Announces 2023 Interim Financial Results and Provides Corporate Updates
Newsfile Corp
2023-08-16
Polypeptide.ltd Announces Intent to Expand Tirzepatide and Retatrutide to Production Capacity of Hig...
Newsfile Corp
2023-05-01
KeraFactor(TM) Introduces an Unprecedented Laser-Assisted Topical Delivery Solution
